PubMed

Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

Kovacs MJ, Rodger M, Anderson DR, Morrow B, Kells G, Kovacs J, Boyle E, Wells PS.

Ann Intern Med. 2003 May 6;138(9):714-9.PMID: 12729425 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism.

Kovacs MJ, Anderson DA, Wells PS.

Pathophysiol Haemost Thromb. 2002 May-Jun;32(3):131-3.PMID: 12372927 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

JAMA. 2005 Feb 9;293(6):681-9.PMID: 15701909 [PubMed - indexed for MEDLINE]Related articlesFree article

Outpatient management of anticoagulation therapy.

du Breuil AL, Umland EM.

Am Fam Physician. 2007 Apr 1;75(7):1031-42. Review.PMID: 17427618 [PubMed - indexed for MEDLINE]Related articles

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators.

JAMA. 2006 Aug 23;296(8):935-42.PMID: 16926353 [PubMed - indexed for MEDLINE]Related articlesFree article

[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]

Míka P, Behounek J, Skoták M, Nevsímal L.

Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44. Czech. PMID: 15456102 [PubMed - indexed for MEDLINE]Related articles

A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism.

Monkman K, Lazo-Langner A, Kovacs MJ.

Thromb Res. 2009 Jul;124(3):275-80. Epub 2009 Jan 19.PMID: 19155056 [PubMed - indexed for MEDLINE]Related articles

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators.

N Engl J Med. 2003 Apr 10;348(15):1425-34. Epub 2003 Feb 24.PMID: 12601075 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.

Heit JA, Berkowitz SD, Bona R, Cabanas V, Corson JD, Elliott CG, Lyons R.

Thromb Haemost. 1997 Jan;77(1):32-8.PMID: 9031445 [PubMed - indexed for MEDLINE]Related articles

The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.

Wells PS, Forgie MA, Simms M, Greene A, Touchie D, Lewis G, Anderson J, Rodger MA.

Arch Intern Med. 2003 Apr 28;163(8):917-20.PMID: 12719200 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators.

N Engl J Med. 2003 Aug 14;349(7):631-9.PMID: 12917299 [PubMed - indexed for MEDLINE]Related articlesFree article

The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.

Deerhake JP, Merz JC, Cooper JV, Eagle KA, Fay WP.

J Thromb Thrombolysis. 2007 Apr;23(2):107-13.PMID: 17221327 [PubMed - indexed for MEDLINE]Related articles

Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.

Caprini JA, Tapson VF, Hyers TM, Waldo AL, Wittkowsky AK, Friedman R, Colgan KJ, Shillington AC; NABOR Steering Committee.

J Vasc Surg. 2005 Oct;42(4):726-33.PMID: 16242561 [PubMed - indexed for MEDLINE]Related articles

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D.

Arch Intern Med. 2002 Aug 12-26;162(15):1729-35.PMID: 12153376 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. A comparison of two methods of starting the anticoagulant drug warfarin.

[No authors listed]

Ann Intern Med. 2003 May 6;138(9):I50. No abstract available. PMID: 12729448 [PubMed - indexed for MEDLINE]Related articlesFree article

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

Clin Ther. 2004 Jul;26(7):1149-59.PMID: 15336480 [PubMed - indexed for MEDLINE]Related articles

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA.

N Engl J Med. 1999 Mar 25;340(12):901-7. Erratum in: N Engl J Med 1999 Jul 22;341(4):298. PMID: 10089183 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.

Phillips EM, Buchan DA, Newman N, Rajan A, Zia S.

Pharmacotherapy. 2005 Oct;25(10):1341-7.PMID: 16185178 [PubMed - indexed for MEDLINE]Related articles

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.

Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J.

Arch Intern Med. 1998 Sep 14;158(16):1809-12.PMID: 9738611 [PubMed - indexed for MEDLINE]Related articlesFree article

Current management of acute symptomatic deep vein thrombosis.

Heit JA.

Am J Cardiovasc Drugs. 2001;1(1):45-50. Review.PMID: 14728051 [PubMed - indexed for MEDLINE]Related articles